Effect of buffers on the stability of SBECD complexes
The effect of 11 buffers as well as the effect of ionic strength were investigated on the binding between the
Tag: SBECD
NIH funds study to evaluate remdesivir for COVID-19 in pregnancy
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
Reviews on remdesivir in Covid-19 treatment
Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent
Successful use of SBECD as vehicle in intravitreal treatment
A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity
Renal and liver injury following the treatment of covid-19 by remdesivir
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19
Happy 70th Birthday, Lajos!
CycloLab celebrates birthday of L. Szente (70), former CEO Lajos Szente has been contributing to the development of the global
Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients
Sedor Pharmaceuticals, LLC (Sedor) announced on November 9, 2020 that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT
Remdesivir dry powder inhalation formulation, pharmacokinetic study in hamsters
Currently, remdesivir is only available as a lyophilized powder for reconstitution and intravenous53 infusion and concentrate solution for dilution and
Use of sulfobutylether beta cyclodextrin for preparing ceramics
A very few patent applications may trace back prior art disclosure to the Neolithic Age (from 10000 – 4500 BC)
Marinus Pharmaceuticals Provides SBECD-enabled Ganaxolone Clinical Data
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced it